Print | Need Larger Text?

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2025-5578

2. Registrant Information.

Registrant Reference Number: S050-2025

Registrant Name (Full Legal Name no abbreviations): Corteva Agriscience Canada Company

Address: 240, 115 Quarry Park Road S.E.

City: Calgary

Prov / State: Alberta

Country: Canada

Postal Code: T2C 5G9

3. Select the appropriate subform(s) for the incident.

Scientific Study

4. Date registrant was first informed of the incident.

5. Location of incident.

6. Date incident was first observed.

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

PMRA Registration No. 29286      PMRA Submission No.       EPA Registration No.

Product Name:

• Active Ingredient(s)
  • FLORASULAM
  • FLUROXYPYR (PRESENT AS 1-METHYLHEPTYL ESTER)

7. b) Type of formulation.

Application Information

8. Product was applied?

Unknown

9. Application Rate.

10. Site pesticide was applied to (select all that apply).

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform VII: Scientific Study

1. Study Reference

Title GF-184: Chronic Toxicity Test with the Earthworm (Eisenia andrei) in Artificial Soil

Date 29-JUL-25

2. a) Is an extension needed to translate the document?

No

3. Type of incident identified in the study

Increased health or environmental risk

4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)

This study may fall under regulation related to: Environmental studies of the toxicity of a pesticide to terrestrial or aquatic wildlife or plants at lower levels in a chronic study than previous studies with similar species.

5. a) Was the study discontinued before completion?

No

5. b) Provide the reason for discontinuation

6. If the study is ongoing, what is the expected completion date?

For Registrant use only

7. Provide supplemental information here